Call us: +44 870 8 200 310
Or write: experts@regartis.com
classification and labelling
| Page | Keyword count |
| TITLE I: GENERAL ISSUES | |
| CHAPTER 1: Aim, scope and application | |
| Article 2: Application | 1 |
| TITLE II: REGISTRATION OF SUBSTANCES | |
| CHAPTER 1: General obligation to register and information requirements | |
| Article 10: Information to be submitted for general registration purposes | 1 |
| CHAPTER 4: Common provisions for all registrations | |
| Article 22: Further duties of registrants | 1 |
| TITLE III: DATA SHARING AND AVOIDANCE OF UNNECESSARY TESTING | |
| CHAPTER 3: Rules for phase-in-substances | |
| Article 29: Substance Information Exchange Forums | 2 |
| TITLE X: AGENCY | |
| Article 76: Composition | 1 |
| TITLE XII: INFORMATION | |
| Article 119: Electronic public access | 2 |
| ANNEX VII: STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF ONE TONNE OR MORE | |
| 9.: ECOTOXICOLOGICAL INFORMATION | 1 |
| ANNEX XI: GENERAL RULES FOR ADAPTATION OF THE STANDARD TESTING REGIME SET OUT IN ANNEXES VII TO X | |
| 1.: TESTING DOES NOT APPEAR SCIENTIFICALLY NECESSARY | |
| 1.1.: Use of existing data | |
| 1.1.1.: Data on physical-chemical properties from experiments not carried out according to GLP or the test methods referred to in Article 13(3) | 1 |
| 1.1.2.: Data on human health and environmental properties from experiments not carried out according to GLP or the test methods referred to in Article 13(3) | 1 |
| 1.3.: Qualitative or Quantitative structure-activity relationship ((Q)SAR) | 1 |
| 1.4.: In vitro methods | 1 |
| 1.5.: Grouping of substances and read-across approach | 1 |
| Appendices 1 to 6 | |
| explanations of column headings: Explanations of column headings | 1 |